Press "Enter" to skip to content

New patent expiration for Merck Sharp drug CRIXIVAN

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Merck Sharp drug CRIXIVAN

Annual Drug Patent Expirations for CRIXIVAN
Annual Drug Patent Expirations for CRIXIVAN

Crixivan is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

This drug has forty-one patent family members in thirty-five countries.

The generic ingredient in CRIXIVAN is indinavir sulfate. One supplier is listed for this compound. Additional details are available on the indinavir sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Merck Sharp drug CRIXIVAN
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions